BeyondSpring is trading up +8.32% now at $0.78 after positive Moderna cancer-vaccine trial results lifted biotechnology sentiment.
- No new company-specific announcement was identified for August 21, 2026.
- Shares closed at $0.72 on August 20, down from $1.00 on August 13, highlighting a volatile week.
- Broader pre-market indices were modestly higher, but the clearest identified catalyst remains sector sentiment.